Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
Weihua Zhou, Daniel Wahl
Cancers (2019) Vol. 11, Iss. 9, pp. 1231-1231
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Weihua Zhou, Yangyang Yao, Andrew J. Scott, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 159
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
Tengfei Huang, Tianqi Xu, Yangfan Wang, et al.
Autophagy (2021) Vol. 17, Iss. 11, pp. 3592-3606
Open Access | Times Cited: 152
Sex-Specific Differences in Glioblastoma
Anna Carrano, Juan José Juárez‐Vignon Whaley, Diego Incontri‐Abraham, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1783-1783
Open Access | Times Cited: 107
Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, Alexander A. Terentiev
Cancers (2020) Vol. 12, Iss. 4, pp. 862-862
Open Access | Times Cited: 136
Radioresistance in Glioblastoma and the Development of Radiosensitizers
Md. Yousuf Ali, Claudia R. Oliva, Abu Shadat Mohammod Noman, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2511-2511
Open Access | Times Cited: 121
Genotoxic therapy and resistance mechanism in gliomas
Fengchao Lang, Yang Liu, Fu-Ju Chou, et al.
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107922-107922
Open Access | Times Cited: 83
Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma
Tomás Duraj, Noemí Garcia‐Romero, Josefa Carrión-Navarro, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 202-202
Open Access | Times Cited: 74
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
Yongjun Kou, Feng Geng, Deliang Guo
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1943-1943
Open Access | Times Cited: 57
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
Antonio C. Fuentes-Fayos, Miguel E. G-García, Jesús M. Pérez‐Gómez, et al.
EBioMedicine (2023) Vol. 90, pp. 104484-104484
Open Access | Times Cited: 33
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 32
POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway
Rui Yang, Mei Wang, Guanghui Zhang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 54
Metabolic heterogeneity and adaptability in brain tumors
Christian E. Badr, Daniel J. Silver, Florian A. Siebzehnrübl, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 24, pp. 5101-5119
Open Access | Times Cited: 53
Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines
Wei Guo, Hor‐Yue Tan, Feiyu Chen, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 404-404
Open Access | Times Cited: 52
Metabolic Drivers of Invasion in Glioblastoma
Joseph H. Garcia, Saket Jain, Manish K. Aghi
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 52
Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review
Sara Momtazmanesh, Nima Rezaei
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival
Kimberly M. Stanke, Carrick Wilson, Srivatsan Kidambi
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 44
Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?
Pavel Burko, Giuseppa D’Amico, Ilia Miltykh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4883-4883
Open Access | Times Cited: 20
When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities
Dan Du, Jing He, Chenxi Ju, et al.
Cancer Letters (2023) Vol. 562, pp. 216165-216165
Closed Access | Times Cited: 19
Multi-omic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations
Joseph H. Garcia, Erin Akins, Saket Jain, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 3
Open Access | Times Cited: 17
SRC Kinase in Glioblastoma: News from an Old Acquaintance
Claudia Cirotti, Claudia Contadini, Daniela Barilà
Cancers (2020) Vol. 12, Iss. 6, pp. 1558-1558
Open Access | Times Cited: 40
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Soumik Pal, Amit Sharma, Sam Padalumavunkal Mathew, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression
Rui Yang, Guanghui Zhang, Zhen Dong, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 4, pp. 635-647
Open Access | Times Cited: 24
Inhibition of O-GlcNAcylation Reduces Cell Viability and Autophagy and Increases Sensitivity to Chemotherapeutic Temozolomide in Glioblastoma
Amanda V. Leonel, Frederico Alisson‐Silva, Ronan Christian Santos, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4740-4740
Open Access | Times Cited: 15
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 6
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Erik R. Peterson, Peter Sajjakulnukit, Andrew J. Scott, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top